Evidence map›Paper›PMID 36644660›Full record

ArticleDigital health

Evaluation of prototype risk prediction tools for clinicians and people living with type 2 diabetes in North West London using the think aloud method.

Clarissa Gardner, Deborah Wake, Doogie Brodie, Alex Silverstein, Sophie Young, Scott Cunningham, Chris Sainsbury, Maria Ilia, Amanda Lucas, Tony Willis and 1 more

Open access · goldAbstract read
In one paragraph

Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Clarissa GardnerDepartment of Surgery and Cancer, Institute of Global Health Innovation, Imperial College London, London, UK.ORCID https://orcid.org/0000-0001-9990-7961
Deborah WakeMyWay Digital Health, Dundee, UK.
Doogie BrodieMyWay Digital Health, Dundee, UK.
Alex SilversteinLocal Care Directorate, NHS North West London Integrated Care Board, London, UK.
Sophie YoungInformation Directorate, Imperial College Health Partners, London, UK.
Scott CunninghamMyWay Digital Health, Dundee, UK.
Chris SainsburyMyWay Digital Health, Dundee, UK.
Maria IliaInformation Directorate, Imperial College Health Partners, London, UK.
Amanda LucasInformation Directorate, Imperial College Health Partners, London, UK.
Tony WillisDiabetes Transformation Team, NHS North West London Collaboration of CCGs, London, UK.
Jack HalliganDepartment of Surgery and Cancer, Institute of Global Health Innovation, Imperial College London, London, UK.ORCID https://orcid.org/0000-0002-8094-5420
Kings Health Partners · GBImperial College London · GBUniversity of Edinburgh · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prevalence of type 2 diabetes in North West London (NWL) is relatively high compared to other parts of the United Kingdom with outcomes suboptimal. This presents a need for more effective strategies to identify people living with type 2 diabetes who need additional support. An emerging subset of web-based interventions for diabetes self-management and population management has used artificial intelligence and machine learning models to stratify the risk of complications from diabetes and identify patients in need of immediate support. In this study, two prototype risk prediction tools on the MyWay Diabetes and MyWay Clinical platforms were evaluated with six clinicians and six people living with type 2 diabetes in NWL using the think aloud method. The results of the sessions with people living with type 2 diabetes showed that the concept of the tool was intuitive, however, more instruction on how to correctly use the risk prediction tool would be valuable. The feedback from the sessions with clinicians was that the data presented in the tool aligned with the key diabetes targets in NWL, and that this would be useful for identifying and inviting patients to the practice who are overdue for tests and at risk of complications. The findings of the evaluation have been used to support the development of the prototype risk predictions tools. This study demonstrates the value of conducting usability testing on web-based interventions designed to support the targeted management of type 2 diabetes in local communities.

Indexed as

artificial intelligencebehaviour changeDiabetesdigital healthhealth informaticsinternetmachine learningpersonalised medicinequalitativerisk factors

Identifiers

PMID36644660
PMCPMC9834412
OpenAlexW4313816007

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.